UK markets closed
NIKKEI 225
33,231.27 -200.24 (-0.60%) HANG SENG
16,646.05 -184.25 (-1.09%) CRUDE OIL
73.32 -0.75 (-1.01%) GOLD FUTURES
2,047.50 -42.20 (-2.02%) DOW
36,204.44 -41.06 (-0.11%) Bitcoin GBP
33,067.48 +1,687.26 (+5.38%)
NVO Jan 2024 130.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:07PM EST. Market open.
| Previous close | 32.26 |
| Open | 32.25 |
| Bid | 22.50 |
| Ask | 27.00 |
| Strike | 130.00 |
| Expiry date | 2024-01-19 |
| Day's range | 32.25 - 32.26 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksCentene (CNC) Wins Contract From Arizona's Medicaid Agency
Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.
ZacksRoche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
Roche (RHHBY) aims to enter the promising and much-in-demand obesity drug market with the acquisition of Carmot Therapeutics, Inc. for $2.7 billion.
ZacksAltimmune (ALT) Rises 83% on Successful Phase II Obesity Study
Altimmune (ALT) reports positive top-line data from its 48-week phase II MOMENTUM study of obesity drug candidate, pemvidutide. The stock gains 83%.
© 2023 Yahoo. All rights reserved.